Cargando…
Use of Phil Embolic Agent for Bleeding in Non-Neurological Interventions
Objective: To evaluate the safety and efficacy of the Phil liquid embolic agent in non-neurological embolization procedures. M&M: Thirty-five patients with a mean age of 62.5 years underwent percutaneous embolization using Phil for the treatment of visceral arterial bleedings in 20/35 patients (...
Autores principales: | Lucatelli, Pierleone, Corona, Mario, Teodoli, Leonardo, Nardis, Piergiorgio, Cannavale, Alessandro, Rocco, Bianca, Trobiani, Claudio, Cipollari, Stefano, Zilahi de Gyurgyokai, Simone, Bezzi, Mario, Catalano, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916888/ https://www.ncbi.nlm.nih.gov/pubmed/33670124 http://dx.doi.org/10.3390/jcm10040701 |
Ejemplares similares
-
Bleeding in COVID Patients: What We Have Understood So Far
por: Lucatelli, Pierleone, et al.
Publicado: (2021) -
Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results
por: Lucatelli, Pierleone, et al.
Publicado: (2019) -
Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
por: Lucatelli, Pierleone, et al.
Publicado: (2021) -
Correction to: Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
por: Lucatelli, Pierleone, et al.
Publicado: (2021) -
Sarcopenia Worsening One Month after Transarterial Radioembolization Predicts Progressive Disease in Patients with Advanced Hepatocellular Carcinoma
por: Vallati, Giulio Eugenio, et al.
Publicado: (2021)